Injectable Drug Delivery to 2024

Wednesday, November 28, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 27, 2018 /PRNewswire/ -- The correlation between chronic conditions and the benefits of patient self-administration

continues to influence therapeutic product decisions, managed care initiatives and regulatory actions.  Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and
packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. The trend toward self-administration of injectables will exert increasing influence on all aspects of the parenteral drug sector.Download the full report: https://www.reportbuyer.com/product/5629015 What You Will Learn• What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?• What are the market drivers influencing syringes and injectors " device designs, feature/functionality, product branding, competing technologies and commercial development?• What are the key characteristics of the major injectable device market segments and what is the impact of market demographics, and competing business strategies?• What is the current market demand for syringes and injectors by indication and therapy and what will it be in 2024?• Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?• What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?Download the full report: https://www.reportbuyer.com/product/5629015 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/injectable-drug-delivery-to-2024-300756084.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store